SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
186 hedge funds and large institutions have $386M invested in Sorrento Therapeutics, Inc. in 2020 Q2 according to their latest regulatory filings, with 105 funds opening new positions, 55 increasing their positions, 19 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
186
Holders Change
+94
Holders Change %
+102.17%
% of All Funds
3.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
105
Increased
55
Reduced
19
Closed
11
Calls
$46M
Puts
$26.9M
Net Calls
+$19.1M
Net Calls Change
+$18.1M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$48.3M |
| 2 |
BlackRock
New York
|
+$23.5M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.1M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$10.5M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$9.42M |
Top Sellers
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$2.6M |
| 2 |
Goldman Sachs
New York
|
-$1.53M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$529K |
| 4 |
IWC
Integrated Wealth Concepts
Waltham,
Massachusetts
|
-$458K |
| 5 |
D.E. Shaw & Co
New York
|
-$435K |
